WHO ICTRP trial
Pharmacokinetics study of two orally formulated combination of acetaminophen and…
ACTRN12618000777291 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618000777291 |
|---|---|
| Public title | Pharmacokinetics study of two orally formulated combination of acetaminophen and ibuprofen (Maxigesic Rapid vs Maxigesic 325) in healthy volunteers under fed condition |
| Scientific title | Randomized, Single Dose, Two-way crossover Open Label to evaluate and compare the pharmacokinetic parameters of 325mg acetaminophen and 97.5mg Ibuprofen film coated tablet, after an oral administration to 30 healthy adults under Fed Condition |
| Primary sponsor | AFT Pharmaceuticals Ltd. |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Jordan |
| Conditions | pain relief; pain relief;Anaesthesiology - Pain management |
| Interventions | Maxigesic® Rapid (Treatment A): Acetaminophen 325 mg and Ibuprofen 97.5mg Single Dose: Oral administration of three film coated tablets with 240ml of water under fed condition (Participants will be fasted for at least 10 hours overnight… |
| Registration date | Sep 5, 2018 |
| Target size | 30 |
| Secondary IDs | ACIT-T009 |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: